Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels

Nature Communications

Volumn 4, Issue , 2013, Pages

  Shi, Limin ^a   Bian, Xiling ^b   Qu, Zhiqiang ^a   Ma, Zegang ^a   Zhou, Yu ^a   Wang, Ke Wei ^b   Jiang, Hong ^a   Xie, Junxia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; DOPAMINE; GHRELIN; GROWTH HORMONE SECRETAGOGUE; HALOPERIDOL; POTASSIUM CHANNEL KCNQ; PROTEIN KINASE;

INHIBITION; NERVOUS SYSTEM; NEUROLOGY; PEPTIDE; POTASSIUM; SIGNAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CATALEPSY; CONTROLLED STUDY; DOPAMINE RELEASE; DYSTONIA; FEMALE; NERVE CELL EXCITABILITY; NERVOUS SYSTEM; NONHUMAN; RAT; SUBSTANTIA NIGRA;

ACTION POTENTIALS; ANIMALS; CA1 REGION, HIPPOCAMPAL; CATALEPSY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINERGIC NEURONS; GANGLIA, SPINAL; GHRELIN; HALOPERIDOL; INJECTIONS, INTRAVENTRICULAR; KCNQ POTASSIUM CHANNELS; MICE; MICE, TRANSGENIC; NYSTATIN; POTASSIUM CHANNEL BLOCKERS; PYRAMIDAL CELLS; RATS; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TYPE C PHOSPHOLIPASES;

EID: 84874620965     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2439     Document Type: Article

References (59)

1. Hansen, H. H. et al. The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine. Eur. J. Pharmacol. 570, 77-88 (2007) (Pubitemid 47247684)
2. Seeman, P. & Kapur, S. Schizophrenia: more dopamine, more D2 receptors. Proc. Natl Acad. Sci. USA 97, 7673-7675 (2000)
3. Lotharius, J. & Brundin, P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3, 932-942 (2002)
4. Jankovic, J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368-376 (2008) (Pubitemid 351441488)
5. Krasnova, I. N., Bychkov, E. R., Lioudyno, V. I., Zubareva, O. E. & Dambinova, S. A. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Neuroscience 95, 113-117 (2000)
6. Salthun-Lassalle, B., Traver, S., Hirsch, E. C. & Michel, P. P. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Mol. Pharmacol. 68, 1214-1224 (2005) (Pubitemid 41539979)
7. Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660 (1999) (Pubitemid 129516334)
8. Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194-198 (2001) (Pubitemid 32144284)
9. Abizaid, A. et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116, 3229-3239 (2006) (Pubitemid 44878637)
10. Diano, S. et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9, 381-388 (2006) (Pubitemid 43290968)
11. Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661 (2003) (Pubitemid 36262986)
12. Andrews, Z. B. et al. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J. Neurosci. 29, 14057-14065 (2009)
13. Osterstock, G. et al. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS ONE 5, e9159 (2010)
14. Koyama, S., Brodie, M. S. & Appel, S. B. Ethanol inhibition of m-current and ethanol-induced direct excitation of ventral tegmental area dopamine neurons. J. Neurophysiol. 97, 1977-1985 (2007) (Pubitemid 46411135)
15. Cooper, E. C., Harrington, E., Jan, Y. N. & Jan, L. Y. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J. Neurosci. 21, 9529-9540 (2001) (Pubitemid 34184041)
16. Ljungstrom, T., Grunnet, M., Jensen, B. S. & Olesen, S. P. Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels. Pflugers Arch. 446, 684-694 (2003) (Pubitemid 37215004)
17. Passmore, G. M. et al. KCNQ/M currents in sensory neurons: significance for pain therapy. J. Neurosci. 23, 7227-7236 (2003) (Pubitemid 36975887)
18. Hansen, H. H. et al. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat. J. Pharmacol. Exp. Ther. 318, 1006-1019 (2006) (Pubitemid 44268305)
19. Miao, Y. et al. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem. Biophys. Res. Commun. 359, 795-800 (2007) (Pubitemid 46899020)
20. Jia, Y. D., Chen, X., Tang, M. & Jiang, Z. Y. [Expression of growth hormone secretagogue receptor type 1a in visceral vagal and spinal afferent parthways]. Sheng Li Xue Bao 60, 149-155 (2008)
21. Roepke, T. A., Qiu, J., Smith, A. W., Ronnekleiv, O. K. & Kelly, M. J. Fasting and 17beta-estradiol differentially modulate the M-current in neuropeptide Y neurons. J. Neurosci. 31, 11825-11835 (2011)
22. Koyama, S. & Appel, S. B. Characterization of M-current in ventral tegmental area dopamine neurons. J. Neurophysiol. 96, 535-543 (2006) (Pubitemid 44155194)
23. Martire, M. et al. Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes. J. Neurochem. 102, 179-193 (2007) (Pubitemid 46906273)
24. Zhang, H. et al. PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents. Neuron 37, 963-975 (2003) (Pubitemid 36398301)
25. Delmas, P. & Brown, D. A. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat. Rev. Neurosci. 6, 850-862 (2005) (Pubitemid 41568727)
26. Suh, B. C. & Hille, B. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4, 5-bisphosphate synthesis. Neuron 35, 507-520 (2002) (Pubitemid 34879949)
27. Mousseaux, D. et al. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway. Br. J. Pharmacol. 148, 350-365 (2006) (Pubitemid 43801182)
28. Dimitrova, D. Z. et al. Contractile effect of ghrelin on isolated guinea-pig renal arteries. Vascul. Pharmacol. 47, 31-40 (2007) (Pubitemid 46824127)
29. Takano, S. et al. Electrophysiological effects of ghrelin on laterodorsal tegmental neurons in rats: an in vitro study. Peptides 30, 1901-1908 (2009)
30. Brown, D. A. & Adams, P. R. Muscarinic suppression of a novel voltagesensitive K current in a vertebrate neurone. Nature 283, 673-676 (1980) (Pubitemid 10099998)
31. Bi, Y. et al. Visceral hyperalgesia induced by forebrain-specific suppression of native Kv7/KCNQ/M-current in mice. Mol. Pain 7, 84 (2011)
32. Biervert, C. et al. A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406 (1998) (Pubitemid 28063379)
33. Brown, D. A. & Passmore, G. M. Neural KCNQ (Kv7) channels. Br. J. Pharmacol. 156, 1185-1195 (2009)
34. Kosenko, A. et al. Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation. EMBO J. 31, 3147-3156 (2012)
35. Shah, M. M., Mistry, M., Marsh, S. J., Brown, D. A. & Delmas, P. Molecular correlates of the M-current in cultured rat hippocampal neurons. J. Physiol. 544, 29-37 (2002) (Pubitemid 35153811)
36. Erriquez, J. et al. Calcium signals activated by ghrelin and D-Lys(3)-GHRP-6 ghrelin antagonist in developing dorsal root ganglion glial cells. Cell Calcium 46, 197-208 (2009)
37. Crozier, R. A., Ajit, S. K., Kaftan, E. J. & Pausch, M. H. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J. Neurosci. 27, 4492-4496 (2007) (Pubitemid 46640701)
38. Peters, H. C., Hu, H., Pongs, O., Storm, J. F. & Isbrandt, D. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat. Neurosci. 8, 51-60 (2005) (Pubitemid 41236731)
39. Griesemer, D., Zawar, C. & Neumcke, B. Cell-type specific depression of neuronal excitability in rat hippocampus by activation of ATP-sensitive potassium channels. Eur. Biophys. J. 31, 467-477 (2002) (Pubitemid 36163887)
40. Wulfsen, I., Hauber, H. P., Schiemann, D., Bauer, C. K. & Schwarz, J. R. Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary. J. Neuroendocrinol. 12, 263-272 (2000) (Pubitemid 30156518)
41. Saganich, M. J., Machado, E. & Rudy, B. Differential expression of genes encoding subthreshold-operating voltage-gated K channels in brain. J. Neurosci. 21, 4609-4624 (2001) (Pubitemid 32565620)
42. Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B. & Elmquist, J. K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 494, 528-548 (2006) (Pubitemid 41791000)
43. Prisco, S., Natoli, S., Bernardi, G. & Mercuri, N. B. Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons. Neuropharmacology 42, 289-296 (2002) (Pubitemid 34230481)
44. Overton, P. G. & Clark, D. Burst firing in midbrain dopaminergic neurons. Brain Res. Brain Res. Rev. 25, 312-334 (1997) (Pubitemid 28070309)
45. Schmidt, W. J., Mayerhofer, A., Meyer, A. & Kovar, K. A. Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? Neurosci. Lett. 330, 251-254 (2002) (Pubitemid 35254047)
46. Blandini, F., Nappi, G., Tassorelli, C. & Martignoni, E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol. 62, 63-88 (2000) (Pubitemid 30252017)
47. Smith, Y. & Villalba, R. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov. Disord. 23(Suppl 3): S534-S547 (2008)
48. Guatteo, E., Cucchiaroni, M. L. & Mercuri, N. B. Substantia nigra control of basal ganglia nuclei. J. Neural Transm. Suppl. 73, 91-101 (2009)
49. Moon, M. et al. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox. Res. 15, 332-347 (2009)
50. Jerlhag, E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict. Biol. 13, 358-363 (2008)
51. Quarta, D. et al. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem. Int. 54, 89-94 (2009)
52. Ge, W. P. et al. Long-term potentiation of neuron-glia synapses mediated by Ca2-permeable AMPA receptors. Science 312, 1533-1537 (2006)
53. Jiang, H., Li, L. J., Wang, J. & Xie, J. X. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp. Neurol. 212, 532-537 (2008)
54. Jiang, H., Luan, Z., Wang, J. & Xie, J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with ironoverload. Neurochem. Int. 49, 605-609 (2006) (Pubitemid 44528090)
55. Jiang, H., Song, N., Wang, J., Ren, L. Y. & Xie, J. X. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem. Int. 51, 32-36 (2007) (Pubitemid 47002045)
56. Zhou, Y., Zhao, Z. Q. & Xie, J. X. Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats. Brain Res. 917, 127-132 (2001) (Pubitemid 32972137)
57. Junxia, X., Hong, J., Wenfang, C. & Ming, Q. Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Exp. Neurol. 182, 483-489 (2003)
58. Nakai, S. et al. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. Eur. J. Pharmacol. 472, 89-97 (2003) (Pubitemid 36830995)
59. Xue, Y., Chen, L., Cui, Q. L., Xie, J. X. & Yung, W. H. Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: an in vivo study. Exp. Neurol. 205, 108-115 (2007). (Pubitemid 46617497)